Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Gains from Sales and Divestitures (2011 - 2013)

Updated

Vistagen Therapeutics' Gains from Sales and Divestitures came in at -$6,000 for FY2024 (year ended Mar 31, 2024).

Analysis

Vistagen Therapeutics (VTGN) Gains from Sales and Divestitures (2011 - 2013) Analysis & Trends

Going back to FY2012, Vistagen Therapeutics' Gains from Sales and Divestitures data covers 5 fiscal years.

  • The FY2024 figure represents the highest annual Gains from Sales and Divestitures since FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -16,700.00
Sep 30, 2013 -16,800.00
Jun 30, 2013 -16,800.00
Dec 31, 2012 -16,800.00
Sep 30, 2012 -16,800.00
Jun 30, 2012 -16,800.00
Mar 31, 2012 16,800.00
Sep 30, 2011 16,748.00
Jun 30, 2011 -16,748.00
API Access

Vistagen Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=VTGN&period=max&api_key=YOUR_API_KEY